Article

Why time-to-price should be a top KPI for pharma 

Sep 23, 2025

•

2 mins read

aMQetmGNHVfTPFuK_timetopriceheader.png

Pharma has long focused on access, but it continues to miss one of the most solvable barriers to it: speed. At BlinkRx, we analyzed thousands of prescription journeys and found a clear pattern — patients who see a price within 15 minutes are 15% more likely to fill. Yet most pharma organizations don’t even track time-to-price, let alone optimize it.

Patients who see a price within 15 minutes are 15% more likely to fill.

Tech companies have known for years that speed drives behavior. Amazon, Shopify, and Google built infrastructure around delivering value instantly — because every second of delay increases drop-off. In pharma, it’s still common for patients to wait 48 hours or more just to see a price. That delay leads to disengagement. According to IQVIA, only 46% of newly written prescriptions are filled — and nearly 1 in 5 are abandoned completely. [Read our white paper] 

Time-to-price is one of the most direct, actionable drivers of fulfillment.

Our data shows that the critical tipping point happens within minutes, not hours. And yet most brand teams don’t know their average time-to-price — or how to improve it — because their infrastructure doesn’t support it.

BlinkRx solves this. We’ve built a prescription journey management platform that gives manufacturers real-time visibility and control — including live claim runs, intelligent script routing, and a digitally integrated pharmacy network with national coverage. That means patients can see a price in minutes, and act on it right away.

Speed is no longer a technical detail — it’s a commercial advantage.

The infrastructure now exists to measure and improve it. The only question is whether pharma is ready to move at the pace patients already expect. [Book a demo →]